Message #4 From:
Stock News Bot Date: August 15, 2006 06:00:00 AM
IOPM News IntraOp Medical Announces Retirement of Board Member; Co-founder Mary Louise Meurk Retires as Director and Secretary
SUNNYVALE, Calif.--(BUSINESS WIRE)--Aug. 15, 2006--IntraOp Medical Corporation (OTCBB:IOPM) announced today that Mary Louise Meurk, one of its co-founders and an award-winning medical physicist, has resigned from her position as director and corporate secretary after more than 10 years of service. Her resignation was effective as of the end of the business day on August 8, 2006.
"Mary Louise has been an outstanding contributor to IntraOp," commented IntraOp Chief Executive Officer and President Donald A. Goer. "Ms. Meurk helped guide the Company during its founding and product development stage, and continued on the board long after she had retired from her other professional commitments. We owe her a great deal of gratitude for her dedicated service over the last 10 years."
Prior to her professional retirement in 1994, Ms. Meurk enjoyed forty years experience as a radiological physicist and is certified by the American Board of Radiology in Radiological Physics. In addition to authoring numerous articles in her field, Ms. Meurk is a Fellow Emeritus of the American College of Radiology and a Fellow in the American Association of Physicists in Medicine. Ms. Meurk received her BA in physics from Wellesley College and furthered her studies at the University of Geneva. She was Assistant Attending Physicist at Memorial-Sloan Kettering, Head of the Division of Radiological Physics at the Zellerbach Saroni Tumor Institute, and was a founder and President of the West Coast Cancer Foundation. In July 2000, Ms. Meurk received an Award for Achievement in Medical Physics from the American Association of Physicists in Medicine.
About IntraOp Medical Corporation
IntraOp Medical Corporation improves the quality of life for cancer patients through the development, manufacturing and sales of its proprietary Mobetron system. The Mobetron is a mobile electron-beam accelerator designed exclusively for intraoperative electron radiation therapy (IOERT), the direct application of radiation to a tumor while a patient is undergoing cancer surgery. The system makes IOERT widely available, cost effective, and simple to deliver because it is easily transportable between operating rooms and does not require a cost-prohibitive, radiation shielded surgical suite. The system is FDA-certified for sale in the United States and has received the equivalent foreign approvals: CE Mark in Europe, JIS in Japan and SDA in China. IntraOp Medical Corporation is based in Sunnyvale, California.
This press release may contain "forward-looking statements" within the meaning of Section 27A of the 1933 Securities Act and Section 21E of the 1934 Securities Exchange Act. Actual results could differ materially, as the result of such factors as competition in the markets for the company's products and services and the ability of the Company to execute its plans. By making these forward-looking statements, the Company can give no assurances that transactions described in this press release will be successfully completed, and undertakes no obligation to update these statements for revisions or changes after the date of this press release.
